- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01753505
Clinical Significance of 64-slice Multidetector Coronary CT Angiography to Evaluate the Prevalence and Severity of Coronary Artery Disease in Renal Transplant Recipients
November 26, 2017 updated by: Yonsei University
The aim of this study is to evaluate the clinical usefulness of 64-slice multidetector coronary CT angiography (MDCTA) in renal transplant recipients who had no previous coronary artery disease (CAD).
Primary endpoint is to assess the prevalence and severity of coronary artery disease in patients post-transplant 6 to 12 months.
CAD can be diagnosed noninvasively with similar accuracy of coronary angiography using MDCTA.
Early detection and intervention of CAD may provide survival benefit in renal transplant recipients.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
93
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of, 120-752
- Severance Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- age ≥ 40 yrs
- renal transplant recipient at post-transplant 6 to 12 months
- stable graft renal function: CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equation ≥45 mL/min/1.75m2
- patients who had no previous CAD
Exclusion Criteria:
- unstable graft renal function
- History of acute kidney injury within 3 months
- Allergic history to contrast agent
- Irregular heart beat
- Multiorgan transplant recipients
- Pregnancy
- Patients who do not consent to this study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: MDCTA
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
prevalence of coronary artery disease
Time Frame: at post-transplant 6 to 12 months.
|
at post-transplant 6 to 12 months.
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
severity of coronary artery disease
Time Frame: at post-transplant 6 to 12 months
|
at post-transplant 6 to 12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2013
Primary Completion (Actual)
July 28, 2014
Study Completion (Actual)
July 28, 2014
Study Registration Dates
First Submitted
December 17, 2012
First Submitted That Met QC Criteria
December 17, 2012
First Posted (Estimate)
December 20, 2012
Study Record Updates
Last Update Posted (Actual)
November 28, 2017
Last Update Submitted That Met QC Criteria
November 26, 2017
Last Verified
November 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- 4-2012-0549
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Kidney Transplant Recipient
-
University of MichiganHoffmann-La RocheCompletedKidney Transplant Recipient | Heart Transplant RecipientUnited States
-
University of ManchesterManchester University NHS Foundation TrustNot yet recruitingKidney Transplant | Kidney Transplant Recipient | Kidney Transplant DonorUnited Kingdom
-
Idelberto BadellNational Institute of Allergy and Infectious Diseases (NIAID)CompletedKidney Transplant RecipientUnited States
-
Oslo University HospitalHelse Sor-Ost (Helse Sør-Øst)Active, not recruitingTransplant Recipient (Kidney)Norway
-
Maimónides Biomedical Research Institute of CórdobaCompletedKidney Transplant | Kidney Transplant Recipient | CMV Specific Immune Response | CMV ReactivationSpain
-
Saglik Bilimleri Universitesi Gazi Yasargil Training...CompletedKidney Transplant Recipient | Kidney Transplant DonorTurkey
-
National Institute of Allergy and Infectious Diseases...Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN); PPD Development...CompletedKidney Transplantation | Renal Transplantation | Renal Transplant RecipientUnited States
-
University of Kansas Medical CenterCompletedPhysical Activity | Diet Modification | Kidney Transplant RecipientUnited States
-
National Institute of Allergy and Infectious Diseases...Clinical Trials in Organ Transplantation; Cooperative Clinical Trials in Pediatric...CompletedKidney Transplant | Kidney Transplant Recipient | Graft Function/Survival | de Novo HLA Antibodies DevelopmentUnited States
-
Mayo ClinicCompletedKidney Transplant Recipient | Blood Pressure ControlUnited States
Clinical Trials on 64-slice Multidetector coronary CT angiography
-
Assistance Publique - Hôpitaux de ParisCompletedArterial Switch Operation | CT Coronary AngiographyFrance
-
Assiut UniversityCompleted
-
Seoul National University HospitalSamsung Medical Center; Seoul St. Mary's Hospital; Asan Medical Center; Seoul National... and other collaboratorsUnknownChest Pain | Coronary Heart Disease RiskKorea, Republic of
-
José OrtizInstituto de Salud Carlos IIICompletedMyocardial Infarction | Coronary Artery Disease | Acute Coronary Syndrome | Cardiac DeathSpain
-
St. Joseph's Healthcare HamiltonCompletedHeart Valve Diseases | Cardiomyopathies | Heart Defects, Congenital | Coronary ArteriosclerosisCanada
-
University of AarhusDanish Heart Foundation; Danish Research Agency; Philips Medical SystemsCompletedAtherosclerosisDenmark
-
Johns Hopkins UniversityToshiba America Medical Systems, Inc.Completed
-
ECRI bvGE Healthcare; HeartFlow, Inc.CompletedHeart Diseases | Cardiovascular Diseases | Multivessel Coronary Artery Disease | Coronary Artery DiseasesBelgium, France, Germany, Italy, Switzerland
-
St. Olavs HospitalNorwegian University of Science and Technology; Helse Nord-Trøndelag HF; Alesund... and other collaboratorsActive, not recruitingNon-ST Elevated Myocardial InfarctionNorway
-
University Hospital of PatrasCompletedCoronary Artery Bypass SurgeryGreece